Structure and Pharmacology of Voltage-Gated Sodium and Calcium Channels.


Journal

Annual review of pharmacology and toxicology
ISSN: 1545-4304
Titre abrégé: Annu Rev Pharmacol Toxicol
Pays: United States
ID NLM: 7607088

Informations de publication

Date de publication:
06 01 2020
Historique:
pubmed: 21 9 2019
medline: 12 11 2020
entrez: 21 9 2019
Statut: ppublish

Résumé

Voltage-gated sodium and calcium channels are evolutionarily related transmembrane signaling proteins that initiate action potentials, neurotransmission, excitation-contraction coupling, and other physiological processes. Genetic or acquired dysfunction of these proteins causes numerous diseases, termed channelopathies, and sodium and calcium channels are the molecular targets for several major classes of drugs. Recent advances in the structural biology of these proteins using X-ray crystallography and cryo-electron microscopy have given new insights into the molecular basis for their function and pharmacology. Here we review this recent literature and integrate findings on sodium and calcium channels to reveal the structural basis for their voltage-dependent activation, fast and slow inactivation, ion conductance and selectivity, and complex pharmacology at the atomic level. We conclude with the theme that new understanding of the diseases and therapeutics of these channels will be derived from application of the emerging structural principles from these recent structural analyses.

Identifiants

pubmed: 31537174
doi: 10.1146/annurev-pharmtox-010818-021757
doi:

Substances chimiques

Calcium Channels 0
Voltage-Gated Sodium Channels 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-154

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL112808
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS025704
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS015751
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS022625
Pays : United States

Auteurs

William A Catterall (WA)

Department of Pharmacology and Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, Washington 98195, USA; email: wcatt@uw.edu.

Michael J Lenaeus (MJ)

Department of Pharmacology and Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, Washington 98195, USA; email: wcatt@uw.edu.

Tamer M Gamal El-Din (TM)

Department of Pharmacology and Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, Washington 98195, USA; email: wcatt@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH